Compare XBIT & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBIT | PINE |
|---|---|---|
| Founded | 2005 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.8M | 352.2M |
| IPO Year | 2015 | 2019 |
| Metric | XBIT | PINE |
|---|---|---|
| Price | $2.27 | $19.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $20.10 |
| AVG Volume (30 Days) | 34.1K | ★ 148.0K |
| Earning Date | 05-08-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 6.29% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $60,532,000.00 |
| Revenue This Year | N/A | $18.63 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $86.87 |
| Revenue Growth | N/A | ★ 15.90 |
| 52 Week Low | $2.09 | $13.10 |
| 52 Week High | $3.61 | $21.99 |
| Indicator | XBIT | PINE |
|---|---|---|
| Relative Strength Index (RSI) | 47.26 | 37.29 |
| Support Level | $2.27 | $18.80 |
| Resistance Level | $2.32 | $19.91 |
| Average True Range (ATR) | 0.04 | 0.61 |
| MACD | 0.01 | -0.13 |
| Stochastic Oscillator | 64.00 | 6.41 |
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.